Insuffisance cardiaque aiguё congestive due au Bevaczumab dans le cancer du sein métastatique: à propos d’un cas

The addition of Bevacizumab to chemotherapy has shown its first-line interest in metastatic breast cancer by improving PFS but not OS. After a certain period of exposure, the appearance of side effects such as acute Congestive heart failure (CHF) has been described during clinical trials; manifested...

Descripción completa

Detalles Bibliográficos
Autores principales: Akimana, Gloria, Onana, Remy, Lkhooyali, Siham, Errihani, Hassan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The African Field Epidemiology Network 2022
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9733456/
https://www.ncbi.nlm.nih.gov/pubmed/36523277
http://dx.doi.org/10.11604/pamj.2022.43.50.34743

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9733456/
https://www.ncbi.nlm.nih.gov/pubmed/36523277
http://dx.doi.org/10.11604/pamj.2022.43.50.34743

Ejemplares similares